Assertio Holdings, Inc. (ASRT) Financials
Newest figures come from the 10-Q for Q1 FY2026, filed May 8, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ASRT SEC filings page.
Assertio Holdings, Inc. (ASRT) reported $102.2M in revenue over the twelve months to Mar 31, 2026, down 14.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Assertio remains gross-profit positive, but shrinking sales and a receivables-heavy cash reversal now sit behind continuing operating losses.
Operating cash flow shifted from$26.4M in FY2024 to-$28.2M in FY2025, breaking the company’s recent positive cash pattern. That reversal coincided with accounts receivable rising from$54.1M to$120.1M , pointing to working-capital absorption as a key reason cash conversion deteriorated.
Gross margin recovered to
Equity fell from
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Assertio Holdings, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Assertio Holdings, Inc. held $63.4M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $28.2M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Assertio Holdings, Inc. scores 52/100 among other emerging companies.
Assertio Holdings, Inc. had 6M shares outstanding at the end of fiscal year 2025. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Assertio Holdings, Inc. scores 96/100 among other emerging companies.
Assertio Holdings, Inc. spent $1.7M on research and development in fiscal year 2025, which was 1.2% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Assertio Holdings, Inc. scores 10/100 among other emerging companies.
Assertio Holdings, Inc. reported revenue of $118.7M in fiscal year 2025, against $125.0M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Assertio Holdings, Inc. scores 28/100 among other emerging companies.
Not available for Assertio Holdings, Inc., and counted as zero in the overall score.
Assertio Holdings, Inc.'s cash, cash equivalents and investments came to $63.4M at the end of fiscal year 2025, against $173.0M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Assertio Holdings, Inc. scores 37/100 among other emerging companies.
Assertio Holdings, Inc. scores -2.58, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($151.9M) relative to total liabilities ($173.0M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Assertio Holdings, Inc. passes 4 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
Assertio Holdings, Inc. reported a net loss of $30.4M while operations used $28.2M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Assertio Holdings, Inc. reported an operating loss of $21.5M against $3.1M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Assertio Holdings, Inc. generated $9.9M in revenue in Q1 2026. This represents a decrease of 62.5% from the same quarter a year earlier. Against the prior quarter it is down 26.7%.
Assertio Holdings, Inc.'s EBITDA was -$12.6M in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 218.6% from the same quarter a year earlier. Against the prior quarter it is down 109.2%.
Assertio Holdings, Inc. reported -$18.9M in net income in Q1 2026. This represents a decrease of 39.3% from the same quarter a year earlier. Against the prior quarter it is down 58.1%.
Cash & Balance Sheet
Assertio Holdings, Inc. held $33.7M in cash against $39.2M in long-term debt as of Q1 2026.
Not reported for Q1 2026.
Not reported for Q1 2026.
Margins & Returns
Assertio Holdings, Inc.'s gross margin was 72.7% in Q1 2026, indicating the percentage of revenue retained after direct costs. This is up 2.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.2 percentage points.
Assertio Holdings, Inc.'s ROE was -24.9% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is down 12.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 12.2 percentage points.
Not shown for Q1 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q1 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
Assertio Holdings, Inc. invested $454K in research and development in Q1 2026. This represents an increase of 3.7% from the same quarter a year earlier. Against the prior quarter it is down 6.6%.
Not reported for Q1 2026.
Not reported for Q1 2026.
ASRT Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.9M-62.5% | $13.5M-57.9% | $49.5M+69.4% | $29.2M-6.1% | $26.5M-18.4% | $32.2M-2.4% | $29.2M-18.0% | $31.1M-24.1% |
| Cost of Revenue | $2.7M-65.2% | $3.3M-71.9% | $13.7M+80.8% | $10.7M+20.1% | $7.8M-30.3% | $11.6M+19.4% | $7.5M+6.9% | $8.9M+86.3% |
| Gross Profit | $7.2M-61.4% | $10.3M-50.0% | $35.8M+65.4% | $18.5M-16.6% | $18.7M-12.1% | $20.6M-11.6% | $21.7M-24.2% | $22.2M-38.6% |
| R&D Expenses | $454K+3.7% | $486K-62.2% | $379K-62.3% | $387K-51.5% | $438K-40.2% | $1.3M+25.6% | $1.0M-23.6% | $798K+58.6% |
| SG&A Expenses | $19.4M-11.6% | $13.1M-38.7% | $16.9M+1.2% | $17.0M-7.8% | $22.0M+18.6% | $21.4M-10.6% | $16.7M-20.4% | $18.4M+9.6% |
| Operating Income | -$18.5M-39.6% | -$11.7M+12.8% | $11.5M+476.6% | -$8.0M-122.1% | -$13.2M-205.1% | -$13.5M+58.3% | -$3.0M+98.7% | -$3.6M-129.1% |
| EBITDA | -$12.6M-218.6% | -$6.0M+12.3% | $17.2M+361.2% | $1.3M-58.8% | -$4.0M-391.7% | -$6.9M+74.9% | $3.7M+101.7% | $3.2M-83.3% |
| Interest Expense | $775K+1.3% | $772K | $770K | $768K | $765K | $0-100.0% | $0 | $0 |
| Income Tax | $45K-81.6% | $181K+166.3% | -$47K-206.8% | $56K-62.4% | $245K+85.6% | -$273K-101.1% | $44K-99.9% | $149K-96.1% |
| Net Income | -$18.9M-39.3% | -$11.9M-13.9% | $11.4M+491.8% | -$16.4M-345.1% | -$13.5M-200.2% | -$10.5M+81.7% | -$2.9M+99.0% | -$3.7M-143.4% |
| EPS (Basic) | -$2.93-38.2% | -$4.55-4036.4% | $0.12+500.0% | -$0.17-325.0% | -$2.12-4140.0% | -$0.11+65.6% | -$0.03+99.1% | -$0.04-126.7% |
| EPS (Diluted) | -$2.93 | -$4.55 | $0.11+466.7% | -$0.17-325.0% | -$2.12 | -$0.11 | -$0.03+99.1% | -$0.04-130.8% |
| Diluted Shares (Avg) | 6M | N/A | 107M+11.7% | 96M+0.8% | 6M | N/A | 95M+16.7% | 95M+35.8% |
ASRT Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $211.3M-26.2% | $267.0M-6.2% | $319.8M+15.9% | $273.8M-2.0% | $286.4M+1.6% | $284.7M-0.6% | $276.0M-27.4% | $279.4M-31.0% |
| Current Assets | $166.9M-21.9% | $216.6M+7.0% | $263.6M+45.5% | $210.2M+18.2% | $213.6M+23.8% | $202.5M+18.4% | $181.2M-2.1% | $177.9M+33.2% |
| Cash & Equivalents | $33.7M-3.7% | $10.2M-79.8% | $38.5M+1.4% | $47.1M+5.3% | $35.0M-56.6% | $50.6M-31.1% | $38.0M-50.6% | $44.7M-36.3% |
| Short-Term Investments | $37.9M-27.6% | $53.2M+7.5% | $54.9M+8.6% | $51.1M+17.1% | $52.3M | $49.5M | $50.6M | $43.6M |
| Inventory | $23.0M-41.6% | $24.1M-37.0% | $24.8M-37.8% | $32.9M-15.9% | $39.4M+2.1% | $38.3M+1.7% | $39.8M-6.8% | $39.1M+107.7% |
| Accounts Receivable | $61.5M-7.2% | $120.1M+121.9% | $141.3M+214.4% | $61.1M+53.1% | $66.3M+55.6% | $54.1M+13.5% | $44.9M-28.1% | $39.9M-4.1% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $135.7M-23.7% | $173.0M+5.7% | $214.0M+47.1% | $180.5M+22.5% | $177.9M+20.6% | $163.7M+10.3% | $145.5M-22.3% | $147.3M-2.4% |
| Current Liabilities | $91.6M-28.9% | $127.5M+11.2% | $166.8M+85.1% | $132.5M+43.8% | $128.8M+39.4% | $114.7M+22.7% | $90.1M-21.2% | $92.2M+16.0% |
| Non-Current Liabilities | $44.1M-10.1% | $45.5M-7.1% | $47.2M-14.8% | $48.0M-13.0% | $49.1M-10.8% | $49.0M-10.9% | $55.4M-24.0% | $55.1M-22.9% |
| Long-Term Debt | $39.2M+0.8% | $39.1M+0.8% | $39.2M+0.8% | $39.0M+0.8% | $38.9M+0.8% | $38.8M+0.8% | $38.8M-0.1% | $38.7M+1.2% |
| Total Equity | $75.6M-30.3% | $94.0M-22.4% | $105.8M-18.9% | $93.3M-29.4% | $108.5M-19.3% | $121.1M-12.3% | $130.5M-32.3% | $132.2M-48.0% |
| Retained Earnings | -$722.4M-5.2% | -$703.5M-4.5% | -$691.6M-4.4% | -$703.0M-6.6% | -$686.7M-4.7% | -$673.1M-3.3% | -$662.6M-11.5% | -$659.7M-109.7% |
Not reported in any period shown, so not listed: Goodwill.
ASRT Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $8.6M+168.3% | -$30.0M-359.5% | -$4.8M-13520.0% | $19.1M+158.4% | -$12.5M-267.0% | $11.5M+102.3% | -$35K-101.4% | $7.4M-60.3% |
| Depreciation & Amortization | $5.8M-37.0% | $5.8M-13.0% | $5.7M-15.9% | $9.3M+37.8% | $9.3M+62.7% | $6.7M+36.7% | $6.8M-34.8% | $6.8M+4.4% |
| Stock-Based Compensation | $725K-34.2% | N/A | N/A | N/A | $1.1M-8.8% | N/A | N/A | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | $0-100.0% | $0 | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | $11.5M+106.0% | -$35K-101.4% | N/A |
| Investing Cash Flow | $15.1M+614.8% | $1.7M+52.0% | -$3.8M+43.2% | -$6.9M+84.0% | -$2.9M | $1.1M+567.8% | -$6.7M-261.9% | -$43.3M-6062.2% |
| Financing Cash Flow | -$189K-70.3% | -$2K+96.6% | -$7K+30.0% | -$69K+8.0% | -$111K+46.1% | -$59K+99.3% | -$10K0.0% | -$75K+99.5% |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
ASRT Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 72.7%+2.1pp | 75.9%+12.0pp | 72.4%-1.8pp | 63.5%-8.0pp | 70.6%+5.1pp | 63.9%-6.6pp | 74.2%-6.0pp | 71.4%-16.9pp |
| Operating Margin | -185.9% | -86.7%-44.8pp | 23.2%+33.7pp | -27.5%-15.9pp | -50.0%-36.6pp | -41.9%+56.1pp | -10.4% | -11.6%-41.9pp |
| Net Margin | -189.8% | -88.1%-55.5pp | 23.1%+33.1pp | -56.0%-44.2pp | -51.1%-37.2pp | -32.6% | -10.0% | -11.8%-32.5pp |
| Return on Equity | -24.9%-12.4pp | -12.7%-4.0pp | 10.8%+13.1pp | -17.5%-14.8pp | -12.5%-9.1pp | -8.7%+32.9pp | -2.2%+142.7pp | -2.8%-6.1pp |
| Return on Assets | -8.9%-4.2pp | -4.5%-0.8pp | 3.6%+4.6pp | -6.0%-4.7pp | -4.7%-3.1pp | -3.7%+16.4pp | -1.1%+72.5pp | -1.3%-3.4pp |
| Current Ratio | 1.82+0.2x | 1.70-0.1x | 1.58-0.4x | 1.59-0.3x | 1.66-0.2x | 1.77-0.1x | 2.01+0.4x | 1.93+0.2x |
| Debt-to-Equity | 0.52+0.2x | 0.42+0.1x | 0.37+0.1x | 0.42+0.1x | 0.36+0.1x | 0.320.0x | 0.30+0.1x | 0.29+0.1x |
| Asset Turnover | 0.050.0x | 0.05-0.1x | 0.150.0x | 0.110.0x | 0.090.0x | 0.110.0x | 0.110.0x | 0.110.0x |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | 35.9%+18.9pp | -0.1%-7.4pp | N/A |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Assertio Holdings, Inc. ASRT | FY2025 | $118.7M | -$30.4M | -25.6% | $151.9M | 37/100 |
| Rockwell Medical, Inc. (DE) RMTI | FY2025 | $69.3M | -$5.3M | -7.7% | $32.3M | 54/100 |
| Anika Therapeutics Inc ANIK | FY2025 | $112.8M | -$11.0M | -9.8% | $257.4M | 71/100 |
| Durect Corp DRRX | FY2024 | $2.0M | -$8.3M | N/A | $59.3M | 45/100 |
Where Assertio Holdings, Inc. Ranks
Frequently Asked Questions
What is Assertio Holdings, Inc.'s annual revenue?
Assertio Holdings, Inc. (ASRT) reported $118.7M in total revenue for fiscal year 2025. This represents a -5.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Assertio Holdings, Inc.'s revenue growing?
Assertio Holdings, Inc. (ASRT) revenue declined by 5.0% year-over-year, from $125.0M to $118.7M in fiscal year 2025.
Is Assertio Holdings, Inc. profitable?
No, Assertio Holdings, Inc. (ASRT) reported a net income of -$30.4M in fiscal year 2025, with a net profit margin of -25.6%.
What is Assertio Holdings, Inc.'s EBITDA?
Assertio Holdings, Inc. (ASRT) had EBITDA of $8.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Assertio Holdings, Inc. have?
As of fiscal year 2025, Assertio Holdings, Inc. (ASRT) had $10.2M in cash and equivalents against $39.1M in long-term debt.
What is Assertio Holdings, Inc.'s gross margin?
Assertio Holdings, Inc. (ASRT) had a gross margin of 70.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Assertio Holdings, Inc.'s operating margin?
Assertio Holdings, Inc. (ASRT) had an operating margin of -18.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Assertio Holdings, Inc.'s net profit margin?
Assertio Holdings, Inc. (ASRT) had a net profit margin of -25.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Assertio Holdings, Inc.'s return on equity (ROE)?
Assertio Holdings, Inc. (ASRT) has a return on equity of -32.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Assertio Holdings, Inc.'s operating cash flow?
Assertio Holdings, Inc. (ASRT) recorded an outflow of $28.2M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Assertio Holdings, Inc.'s total assets?
Assertio Holdings, Inc. (ASRT) had $267.0M in total assets as of fiscal year 2025, including both current and long-term assets.
How much does Assertio Holdings, Inc. spend on research and development?
Assertio Holdings, Inc. (ASRT) invested $1.7M in research and development during fiscal year 2025.
What is Assertio Holdings, Inc.'s current ratio?
Assertio Holdings, Inc. (ASRT) had a current ratio of 1.70 as of fiscal year 2025, which is generally considered healthy.
What is Assertio Holdings, Inc.'s debt-to-equity ratio?
Assertio Holdings, Inc. (ASRT) had a debt-to-equity ratio of 0.42 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Assertio Holdings, Inc.'s return on assets (ROA)?
Assertio Holdings, Inc. (ASRT) had a return on assets of -11.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
How does Assertio Holdings, Inc.'s liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Assertio Holdings, Inc. (ASRT) held $63.4M in cash, cash equivalents and investments, and reported an operating cash outflow of $28.2M over that year. Dividing the one by the other, the reported balance equals about 27 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Assertio Holdings, Inc.'s Altman Z-Score?
Assertio Holdings, Inc. (ASRT) has an Altman Z-Score of -2.58, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Assertio Holdings, Inc.'s Piotroski F-Score?
Assertio Holdings, Inc. (ASRT) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Assertio Holdings, Inc.'s earnings high quality?
Assertio Holdings, Inc. (ASRT) reported a net loss of $30.4M while operations used $28.2M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Assertio Holdings, Inc. cover its interest payments?
Assertio Holdings, Inc. (ASRT) reported an operating loss of $21.5M against $3.1M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Assertio Holdings, Inc.?
Assertio Holdings, Inc. (ASRT) scores 37 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.